The Know ALL website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know ALL cannot guarantee the accuracy of translated content. Know ALL and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
What questions should I ask my doctor during my initial appointment following a diagnosis of ALL?
Peter Jerrett
September 5, 2025
Know ALL cannot guarantee the accuracy of the automatic subtitles and translations as AI is used for their creation. Please be advised to exercise caution when precise interpretation is required.
For World ALL Day 2025, Know ALL spoke with Peter Jerrett, Know ALL Ambassador and patient from London, UK. We asked, What questions should I ask my doctor during my initial appointment?
During this interview, Peter Jerrett shared practical advice for patients preparing to meet with their doctor after a new diagnosis of acute lymphoblastic leukemia (ALL). Peter recommended preparing in advance by bringing a notebook to record information, note unfamiliar terms, and ensure important questions are not forgotten during what can be an overwhelming time. Bringing a trusted person to appointments can offer additional perspective. They canalso help recall details and contribute their own questions. Peter also emphasized the importance of asking anything that feels important to you, no matter how small itmay seem. He then explored a variety of topics, including details about diagnosis, treatment options, lifestyle considerations, and fertility. Peter concluded by providing reassurancethat there will be many opportunities to discuss questions with healthcare professionals throughout their treatment journey, so there’s no needto worry if you forget something.
This educational resource is independently supported by Amgen. All content was developed by SES in collaboration with an expert ambassador group. Funders were allowed no influence on the content of this resource.
